The identification of recurrent gene fusions in common epithelial cancers—for example, TMPRSS2/ERG in prostate cancer and EML4/ALK in nonsmall cell lung carcinomas—has raised the question of whether fusion genes are pathogenetically important also in ovarian carcinomas. The gene discussed is TMPRSS2; the disease is ovarian carcinoma.